On the other hand, Yamabe et al. reported that the administration of Hachimijiogan possessed a protective effect against the progression of diabetic nephropathy but had no effect on the insulin content in pancreas in a type 2 diabetic model, OLETF rats [32]. Here, INS is linked to diabetic kidney disease.